β-Cryptoxanthin improves hepatic insulin resistance and inflammation through alternative activation of macrophages in diet-induced nonalcoholic fatty liver disease
β-Cryptoxanthin induces an M2-dominant shift in macrophage/Kupffer cells and improves hepatic insulin resistance and inflammation in diet-induced nonalcoholic steatohepatitis